MT
Manoj Tripathi
About Manoj Tripathi
Data last updated:
Manoj Tripathi is a Director at Du Laboratories Limited (since 2018). The company operates in Pharma. Du Laboratories Limited reported revenue of ₹1.98 Cr (FY 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Du Laboratories Limited U24232WB2007PLC121073 | Director | 01 Feb 2018 | 2007 | ₹1.98 Cr (FY 2018) | Active |
Board colleagues of Manoj Tripathi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anish | 06580836 | Du Laboratories Limited | Director |
| Divakar Goli | 03619652 | Du Laboratories Limited | Director |
| Jitendra Kumar Roy | 03619542 | Du Laboratories Limited | Director |
| Kanhaiya Yadav | 03619733 | Du Laboratories Limited | Director |
| Manish Guttedar Mallikayya | 07538689 | Du Laboratories Limited | Director |
| Pavagada Shivaprasad Ravi | 03619700 | Du Laboratories Limited | Director |
| Rabi Shankar Singh | 03619724 | Du Laboratories Limited | Director |
| Vanishree Beturao | 06580780 | Du Laboratories Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manoj Tripathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manoj Tripathi
Manoj Tripathi currently holds 1 directorship: Du Laboratories Limited (Director, since 01 Feb 2018, revenue ₹1.98 Cr (FY 2018)).
Manoj Tripathi was first appointed on 01 Feb 2018 as Director at Du Laboratories Limited.
The current boards of Manoj Tripathi's companies include Anish (Du Laboratories Limited), Divakar Goli (Du Laboratories Limited), Jitendra Kumar Roy (Du Laboratories Limited), Kanhaiya Yadav (Du Laboratories Limited), Manish Guttedar Mallikayya (Du Laboratories Limited), Pavagada Shivaprasad Ravi (Du Laboratories Limited), among others.